Celgene Corp
Change company Symbol lookup
Select an option...
CELG Celgene Corp
MLSS Milestone Scientific Inc
BAC Bank of America Corp
IMKTA Ingles Markets Inc
III Information Services Group Inc
HVRRY Hannover Rueck SE
HVRRF Hannover Rueck SE
HNFSB Hanover Foods Corp
HNFSA Hanover Foods Corp
HJLI Hancock Jaffe Laboratories Inc
Go

Health Care : Biotechnology | Large Cap BlendCompany profile

Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide). Its clinical trial activity includes trials across the disease areas of hematology, solid tumors, and inflammation and immunology. The Company also markets ISTODAX, which is an epigenetic modifier. The Company is also evaluating AG-221 (enasidenib) in combination with VIDAZA in newly diagnosed acute myeloid leukemia with isocitrate dehydrogenase-2 mutations.

Closing Price
$110.02
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
110.26
Day's Low
109.71
Volume
(Average)
Volume:
4,344,437

10-day average volume:
4,656,375
4,344,437
  • Prev Close
    110.02
  • Today's Open
    110.23
  • Day's Range
    109.71-110.26
  • Avg Vol (10-day)
    4.7M
  • Last (time)
    4:00p ET 11/15/19
  • Last (size)
    3
  • 52-Wk Range
    58.59 - 110.70
    LowHigh
  • (12/26/18 - 11/13/19)
    0.61%
  • 29.9%
  • Market Cap
    78.3B
  • Shares Outstanding
    711.7M
  • 8.02
  • 13.72x
  • No dividend
  • Ex-dividend
    No dividend
  • 1.4
  • 71.48
  • (% of float 10/31/19)
    1.82

Latest News

November 15, 2019
6:39 pm ET
BusinessWire
5:43 pm ET
MarketWatch
4:55 pm ET
BusinessWire
7:30 am ET
BusinessWire
6:59 am ET
BusinessWire
November 13, 2019
3:30 pm ET
PR Newswire
November 12, 2019
9:14 am ET
Zacks
9:00 am ET
PR Newswire
7:02 am ET
Globe Newswire
6:59 am ET
BusinessWire
1:25 am ET
Accesswire
November 08, 2019
2:24 pm ET
MarketWatch
12:33 pm ET
BusinessWire
November 07, 2019
6:58 am ET
BusinessWire
November 06, 2019
9:06 am ET
BusinessWire
1:16 am ET
Accesswire
November 05, 2019
4:05 pm ET
Globe Newswire
9:00 am ET
PR Newswire
6:59 am ET
BusinessWire
November 01, 2019
6:59 am ET
BusinessWire
October 31, 2019
7:43 am ET
MarketWatch
7:32 am ET
MarketWatch
7:32 am ET
MarketWatch
7:31 am ET
MarketWatch
7:30 am ET
BusinessWire
October 30, 2019
6:59 am ET
BusinessWire
October 23, 2019
1:45 am ET
Accesswire
October 22, 2019
1:30 pm ET
BusinessWire
9:00 am ET
PR Newswire
7:30 am ET
PR Newswire
October 21, 2019
12:05 am ET
BusinessWire
October 18, 2019
6:59 am ET
BusinessWire
October 16, 2019
6:00 am ET
BusinessWire
October 10, 2019
6:30 am ET
Accesswire
October 09, 2019
1:50 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.